SCHEMBL276848

SCHEMBL276848

CCCCCCCCCN(C=O)CCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1C P00326 3/20 0.52
ADH1A P07327 3/20 0.52
ADH4 P08319 3/20 0.52
DNM1 Q05193 4/20 0.48
TSHR P16473 3/20 0.46
ADH1B P00325 2/20 0.42
ADH7 P40394 2/20 0.42
EPHX1 P07099 1/20 0.42
THRB P10828 1/20 0.42
FAAH O00519 2/20 0.41
TRPV1 Q8NER1 1/20 0.41
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
S1PR2 O95136 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3954905 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL7774990 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL276871 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL5479572 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL277587 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL3962903 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL55195 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL5175186 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL95389 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR
SCHEMBL102600 1.00 ADH1C (0.52) ADH1CADH1AADH4DNM1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1598331-B1 Process for the preparation of phthalic acid dichloride SALTIGO GMBH (DE) 2009-07-15 EP claimed
US-7154003-B2 Process for preparing phthaloyl chloride LANXESS DEUTSCHLAND GMBH (DE) 2006-12-26 US claimed
US-20050277788-A1 Process for preparing phthaloyl chloride LANXESS DEUTSCHLAND GMBH (DE) 2005-12-15 US claimed
EP-1598331-A1 Process for the preparation of phthalic acid dichloride Lanxess Deutschland GmbH (DE) 2005-11-23 EP claimed
CN-115485431-B Treatment agent for synthetic fibers, and method for treating synthetic fibers 竹本油脂株式会社 2023-09-26 CN disclosed
US-11597873-B2 Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency FLOTEK CHEMISTRY, LLC (US) 2023-03-07 US disclosed
US-11407930-B2 Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons FLOTEK CHEMISTRY, LLC (US) 2022-08-09 US disclosed
US-20220073812-A1 DILUTED MICROEMULSIONS WITH LOW SURFACE TENSIONS FLOTEK CHEMISTRY, LLC (US) 2022-03-10 US disclosed
US-11254856-B2 Methods and compositions for use in oil and/or gas wells FLOTEK CHEMISTRY, LLC (US) 2022-02-22 US disclosed
US-20210371730-A1 WELL TREATMENT COMPOSITIONS AND METHODS COMPRISING CERTAIN MICROEMULSIONS AND CERTAIN CLAY CONTROL ADDITIVES EXHIBITING SYNERGISTIC EFFECT OF ENHANCING CLAY SWELLING PROTECTION AND PERSISTENCY FLOTEK CHEMISTRY, LLC (US) 2021-12-02 US disclosed
US-11180690-B2 Diluted microemulsions with low surface tensions FLOTEK CHEMISTRY, LLC (US) 2021-11-23 US disclosed
US-20210340435-A1 METHODS AND COMPOSITIONS FOR STIMULATING THE PRODUCTION OF HYDROCARBONS FROM SUBTERRANEAN FORMATIONS FLOTEK CHEMISTRY, LLC (US) 2021-11-04 US disclosed
US-20070255064-A1 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids BASF AKTIENGESELLSCHAFT (DE) 2007-11-01 US disclosed
EP-1845090-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2007-10-17 EP disclosed
US-7154003-B2 Process for preparing phthaloyl chloride LANXESS DEUTSCHLAND GMBH (DE) 2006-12-26 US disclosed
EP-1667519-A1 SURFACTANT/SOLVENT MIXTURES Bayer CropScience GmbH (DE) 2006-06-14 EP disclosed
US-20050277788-A1 Process for preparing phthaloyl chloride LANXESS DEUTSCHLAND GMBH (DE) 2005-12-15 US disclosed
EP-1598331-A1 Process for the preparation of phthalic acid dichloride Lanxess Deutschland GmbH (DE) 2005-11-23 EP disclosed
WO-2005036962-A1 SURFACTANT/SOLVENT MIXTURES BAYER CROPSCIENCE GMBH (DE) 2005-04-28 WO disclosed
US-20050064004-A1 Surfactant/solvent mixtures BAYER CROPSCIENCE GMBH (DE) 2005-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277788-A1 Process for preparing phthaloyl chloride PHYKPL, PFAS, PGLS ADH1C 2554/4885ADH1A 3390/4885ADH4 3095/4885
US-20070255064-A1 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids CBR3, SCO2, PRMT5 ADH1C 2471/4885ADH1A 3298/4885ADH4 2088/4885
US-20050064004-A1 Surfactant/solvent mixtures C1R, C1S, HRH4 ADH1C 771/4885ADH1A 1067/4885ADH4 3389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.